Notably, C5 and CH50 levels in individuals with clinical manifestations were extremely low or below the limit of quantification (LoQ) of the assay used, supporting a functional C5 deficiency in these individuals. The gene discussed is C5; the disease is hyperinsulinemic hypoglycemia, familial, 4.